The BalancedInvestor Club

NVS Market Analysis

Overview

Fundamentals

P/E ratio21.00Forward 16.39
EPS (TTM)$6.98-9.3% YoY
Profit margin23.9%HEALTHCARE
Market cap$279.67BMega cap

Wall Street coverage

$153.87median target· current $97.73 (+57.4%)12 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
16.39
PEG ratio
2.56
P/B
7.26
P/S (TTM)
4.94
EV/EBITDA
14.30

Profitability & growth

ROE (TTM)
34.9%
Operating margin
30.5%
Revenue growth YoY
-0.7%
Dividend yield
3.2%
Beta
0.49
Last earnings
Apr 27, 2026 · Estimate $2.07 · Reported $1.99
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Novartis AG ADR

Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.

Classification

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
LICHTSTRASSE 35, BASEL, SWITZERLAND
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$279.67B
Shares outstanding$1.91B
52W high$165.43
52W low$101.83

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer